Significant Ownership of Chee Kong Choo

Signature - Title
/s/ Choo Chee Kong - Choo Chee Kong / Chairman and Director of CytoMed Therapeutics Limited
Location
Singapore, Singapore
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Chee Kong Choo.

Notify me when Chee Kong Choo files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Chee Kong Choo

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GDTC CytoMed Therapeutics Limited Ordinary Shares 22% $5,046,105 -$166,879 2,587,746 -3.2% Choo Chee Kong 29 Oct 2025

Schedules 13D/G Reported by Chee Kong Choo:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.